| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 11, 2002
Medical Biochemistry, University of Aarhus, Aarhus-C DK-8000
Corresponding Author: phj{at}biokemi.au.dk
The parkin protein is important for the survival of the neurons that degenerate in Parkinson's disease as demonstrated by disease causing lesions in the parkin gene. The Chinese hamster ovary and the SH-SY5Y cell line stably expressing recombinant human parkin combined with epitope-specific parkin antibodies were used to investigate the proteolytic processing of human parkin during apoptosis by immunoblotting. Parkin is cleaved during apoptosis induced by okadaic acid, staurosporine and camptothecin thereby generating a 38-kDa C-terminal fragment and a 12-kDa N-terminal fragment. The cleavage was not significantly affected by the disease causing mutations K161N, G328E, T415N and G430D and the polymorphism R366W. Parkin and its 38-kDa proteolytic fragment is preferentially associated with vesicles, thereby indicating that cleavage is a membrane-associated event. The proteolysis is sensitive to inhibitors of caspases. The cleavage site was mapped by site-directed mutagenesis of potential aspartic residues and revealed that mutation of Asp126 alone abrogated the parkin cleavage. The tetrapeptide aldehyde LHTD-CHO, representing the amino acid sequence N-terminal to the putative cleavage site was an efficient inhibitor of parkin cleavage. This suggests that parkin function is compromised in neuropathological states associated with an increased caspase activation thereby further adding to the cellular stress.
J. Biol. Chem, 10.1074/jbc.M111534200
Submitted on December 4, 2001
Revised on February 11, 2002
Accepted on February 11, 2002
Caspase-mediated parkin cleavage in apoptotic cell death
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity J. Biol. Chem., February 4, 2005; 280(5): 3390 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Chan, W. Fu, P. Zhang, A. Cheng, J. Lee, K. Kokame, and M. P. Mattson Herp Stabilizes Neuronal Ca2+ Homeostasis and Mitochondrial Function during Endoplasmic Reticulum Stress J. Biol. Chem., July 2, 2004; 279(27): 28733 - 28743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M.K. Muqit, S. M. Davidson, M. D. Payne Smith, L. P. MacCormac, S. Kahns, P. H. Jensen, N. W. Wood, and D. S. Latchman Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival Hum. Mol. Genet., January 1, 2004; 13(1): 117 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-B. Lucking, V. Chesneau, E. Lohmann, P. Verpillat, C. Dulac, A.-M. Bonnet, F. Gasparini, Y. Agid, A. Durr, and A. Brice Coding Polymorphisms in the Parkin Gene and Susceptibility to Parkinson Disease Arch Neurol, September 1, 2003; 60(9): 1253 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kahns, M. Kalai, L. D. Jakobsen, B. F. C. Clark, P. Vandenabeele, and P. H. Jensen Caspase-1 and Caspase-8 Cleave and Inactivate Cellular Parkin J. Biol. Chem., June 20, 2003; 278(26): 23376 - 23380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Darios, O. Corti, C. B. Lucking, C. Hampe, M.-P. Muriel, N. Abbas, W.-J. Gu, E. C. Hirsch, T. Rooney, M. Ruberg, et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death Hum. Mol. Genet., March 1, 2003; 12(5): 517 - 526. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
